About Veradermics
Veradermics is a private company based in New Haven, Connecticut, incorporated in 2021 in Delaware. It has reported $239,281,481 raised in five offerings on Form D since October 2020. Its chief executive is Reid Waldman.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 14, 2025 | Oct 28, 2025 | $134,999,978of $149.9M target | 40 | $3.3M | EquityRule 506(b) | Form D ↗ |
| Nov 25, 2024 | Dec 10, 2024 | $66,567,075of $75.0M target | 40 | $1.6M | EquityRule 506(b) | Form D ↗ |
| Apr 25, 2023 | May 1, 2023 | $15,000,000fully sold | 16 | $937K | EquityRule 506(b) | Form D ↗ |
| Sep 22, 2021 | Oct 6, 2021amended Oct 7, 2021 | $22,238,328fully sold | 41 | $542K | Equity, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Sep 29, 2020 | Oct 9, 2020 | $476,100of $1.5M target | 1 | $476K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, five offerings | $239,281,481 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Veradermics's Form D filed Oct 28, 2025.
PE
Patrick Enright
Director
KP
Katarina Pance
Director
AB
Amanda Birdsey-Benson
Director
JC
John Childs
Director
VC
Vladimir Coric
Director
JK
Jane Grant-Kels
Director
RW
Reid Waldman
Chief Executive Officer and director
Earlier filings also listed Christopher Eklund (director, last listed Dec 2024) and Timothy Durso (president and director, last listed May 2023).